missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CSPG5 Polyclonal Antibody

Description
In direct ELISAs, approximately 25% cross-reactivity with recombinant human Neuroglycan C is observed. Reconstitute at 0.2 mg/mL in sterile PBS.
Neuroglycan C is a transmembrane chondroitin sulfate proteoglycan that is exclusively expressed in the central nervous system. NGC gene expression is developmentally regulated being altered by addiction to psychostimulants and by nerve lesion. Its core protein has a particular multidomain structure differing from those of other known proteoglycans, and this protein is modified post-translationally in various ways such as phosphorylation and glycosylation. Neuroglycan C is a novel part-time proteoglycan that changes its structure from a proteoglycan form to a non-proteoglycan form without chondroitin sulfate chains during the development of the cerebellum and retina. Evidence suggests that Neuroglycan C is involved in neuronal circuit formation in the central nervous system.
Specifications
Specifications
| Antigen | CSPG5 |
| Applications | Immunohistochemistry (Frozen), Western Blot |
| Classification | Polyclonal |
| Concentration | 0.2 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 5% trehalose and No Preservative |
| Gene | CSPG5 |
| Gene Accession No. | Q71M36, Q9ERQ6 |
| Gene Alias | acidic leucine-rich EGF-like domain-containing brain protein; Caleb; chondroitin sulfate proteoglycan 5; chondroitin sulfate proteoglycan 5 (neuroglycan C); Cspg5; MGC44034; Neuroglycan C; Ngc |
| Gene Symbols | CSPG5 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?